Following Professor Ruilope’s insights on the evidence for combining CCBs and ARBs, Professor Rainer Düsing addresses why so many patients require more than one antihypertensive therapy and explores the benefits of single-pill combinations over multiple therapies administered individually.
What are the benefits of single-pill combinations in hypertension? In the opening part of this video, Professor Düsing looks at the role of combination therapy in the management of hypertension and why monotherapy with a single agent is frequently insufficient.
What are the benefits of single-pill combinations in hypertension? In the second part of this video, Professor Düsing addresses the problems with offering combined therapy as separate pills and looks at the tolerability and guideline recommendations for single pill combination therapies.